Get started
Author

Pelin Cinar

Metastatic Pancreatic Cancer: ASCO Guideline Update
2020 · Davendra P.S. Sohal, Erin B. Kennedy, et al. · Journal of Clinical Oncology · 310
Survival for Patients With Invasive Cutaneous Melanoma Among Ethnic Groups: The Effects of Socioeconomic Status and Treatment
2007 · Jason A. Zell, Pelin Cinar, et al. · Journal of Clinical Oncology · 176
PDF
Safety at the Time of the COVID-19 Pandemic: How to Keep Our Oncology Patients and Healthcare Workers Safe
2020 · Pelin Cinar, Timothy Kubal, et al. · Journal of the National Comprehensive Cancer Network · 112
PDF
Early Response Assessment in Pancreatic Ductal Adenocarcinoma Through Integrated PET/MRI
2018 · Zhen J. Wang, Spencer Behr, et al. · American Journal of Roentgenology · 42
Implementation of an Embedded In-Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic Adenocarcinoma
2021 · Evan J. Walker, Dena Goldberg, et al. · The Oncologist · 38
PDF
Phase 2 trial of the indoleamine 2,3-dioxygenase pathway (IDO) inhibitor indoximod plus gemcitabine/nab-paclitaxel for the treatment of metastatic pancreas cancer: Interim analysis.
2016 · Nathan Bahary, Ignacio Garrido-Laguna, et al. · Journal of Clinical Oncology · 36
Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes
2020 · Pelin Cinar, John Cox, et al. · JCO Oncology Practice · 31
CA 19-9 Response
2019 · Celso L. Diaz, Pelin Cinar, et al. · American Journal of Clinical Oncology · 29
Phase II study of pembrolizumab-based therapy in previously treated extrapulmonary poorly differentiated neuroendocrine carcinomas: Results of Part A (pembrolizumab alone).
2019 · Claire Mulvey, Nitya Prabhakar Raj, et al. · Journal of Clinical Oncology · 24
Monoclonal Antibodies and Other Targeted Therapies for Pancreatic Cancer
2012 · Pelin Cinar, Margaret A. Tempero · The Cancer Journal · 22
Phase II study of pembrolizumab plus capecitabine and bevacizumab in microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Interim analysis.
2021 · Andrea Grace Bocobo, Renee Wang, et al. · Journal of Clinical Oncology · 17
Planning for post‐pandemic cancer care delivery: Recovery or opportunity for redesign?
2020 · Pelin Cinar, Richard Bold, et al. · CA A Cancer Journal for Clinicians · 17
PDF
Phase II trial of pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC).
2018 · Robin Kate Kelley, Emily Mitchell, et al. · Journal of Clinical Oncology · 15
Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases
2022 · Nicholas Fidelman, Chloe E. Atreya, et al. · BMC Cancer · 14
PDF
Phase 2 trial of pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC): Clinical outcomes and biomarker analyses.
2018 · Robin Kate Kelley, Emily Mitchell, et al. · Journal of Clinical Oncology · 14
Abstract GS1-09: Sacituzumab govitecan vs chemotherapy as first therapy after endocrine therapy in HR+/HER2− (IHC 0, 1+, 2+/ISH−) metastatic breast cancer: Primary results from ASCENT-07
2026 · K. L. Jhaveri, Y. Park, et al. · Clinical Cancer Research · 11
Abstract PO1-05-09: ASCENT-07: A phase 3, randomized, open-label study of sacituzumab govitecan versus treatment of physician’s choice in patients with HR+/HER2– inoperable, locally advanced, or metastatic breast cancer post-endocrine therapy
2024 · Hope Rugo, Javier Cortés, et al. · Cancer Research · 9
Pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC): Final outcomes of a phase 2 trial.
2022 · Robin Kate Kelley, Paige M. Bracci, et al. · Journal of Clinical Oncology · 9
A step towards equitable clinical trial recruitment: a protocol for the development and preliminary testing of an online prostate cancer health information and clinical trial matching tool
2019 · Hala T. Borno, Brian M. Bakke, et al. · Pilot and Feasibility Studies · 9
PDF
A case series of patients with HER2-overexpressed primary metastatic gastroesophageal adenocarcinoma.
2014 · Pelin Cinar, Sarah M Calkins, et al. · PubMed · 8
An AI model classifies risks of early relapse post–CAR T-cell therapy in a multicenter real-world population with DLBCL
2025 · Michelle Wang, Krishna V. Komanduri, et al. · Blood Advances · 7
PDF
COVID-19 Outcomes Among Patients With Cancer: Observations From the University of California Cancer Consortium COVID-19 Project Outcomes Registry
2022 · Hala T Borno, Mi-Ok Kim, et al. · The Oncologist · 7
Phase II study of pembrolizumab plus capecitabine and bevacizumab in microsatellite stable (MSS) metastatic colorectal cancer (mCRC).
2022 · Andrea Grace Bocobo, Renee Wang, et al. · Journal of Clinical Oncology · 6
Evolving Treatment Options for Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma
2014 · Pelin Cinar, Andrew H. Ko · Journal of the National Comprehensive Cancer Network · 5
PDF
Pediatric and AYA invasive cutaneous melanoma: Population-based study comparing adult melanoma cases
2008 · P. Cinar, J. A. Zell, et al. · Journal of Clinical Oncology · 5
Works count: 71
Citation count: 1,007
H-index: 14
I10-index: 16
Year
Topic
Type